About
Dana Sun is a Senior Associate on the Digital Health investing team, focusing on health technology companies transforming how patients, providers, and payers experience and deliver care in today’s evolving ecosystem. Dana was a member of the deal team for OCA’s investments in OssoVR, BioROSA, eBlu Solutions, iPill, HealtheMed, and Biotia.
Prior to joining OCA Ventures, Dana partnered with global teams across commercial and R&D functions to drive strategic decision-making while at Genentech. Dana also brings experience from her prior roles doing early stage healthcare investing at Towerview Ventures and incubating companies at ‘87 (part of Sterling Partners). She began her career as a management consultant at Accenture, where she primarily advised payer, provider, and pharma clients on business and technology strategy.
Dana earned an MBA from the University of Chicago Booth School of Business and a BSE in Biomedical Engineering from Duke University.
Go to karaoke song: Blank Space by Taylor Swift